TRLV — Trulieve Cannabis Corp. stock price, charts and financials

QT84Trulieve Cannabis Corp.

Trulieve Cannabis Corp. (NYSE: TRLV) is a Healthcare company in the Drug Manufacturers - Specialty & Generic industry. QuoTrend tracks its price, financials, earnings, analyst ratings and insider trades.

Latest market price
11.07
-0.58-4.98%
OverviewShort InterestFilings
TRLVQT84Trulieve Cannabis Corp.·NYSE
11.07-4.98%
TA
Loading chart...
Screen all →
ALVO+9.93%$5.87PRGO+0.59%$13.56BHC+0.35%$5.67ANIP+0.99%$76.14HCM-1.09%$13.67SUPN-2.14%$42.00ETON-2.75%$55.50PAHC+0.32%$34.56
Snapshot
Index-P/E-EPS (ttm)-2.45Insider Own1.79%Shs Outstand169.90MPerf Week-2.12%
Market Cap1.96BForward P/E19.25EPS next Y0.57Insider Trans-55.92%Shs Float162.36MPerf Month9.71%
Enterprise Value2.24BPEG-EPS next Q0.09Inst Own-Short Float0.89%Perf Quarter9.60%
Income-72.13MP/S1.68EPS this Y25.63%Inst Trans-Short Ratio1.11Perf Half Y74.61%
Sales1.17BP/B1.90EPS next Y131.56%ROA-2.94%Short Interest1.44MPerf YTD27.39%
Book/sh-P/C8.00EPS next 5Y-ROE-6.88%52W High13.28 -16.64%Perf Year59.51%
Cash/sh-P/FCF8.27EPS past 3/5Y-ROIC-5.03%52W Low4.62 139.61%Perf 3Y69.01%
Dividend Est.-EV/EBITDA6.89Sales past 3/5Y-Gross Margin54.60%Volatility6.72% 6.43%Perf 5Y-56.14%
Dividend TTM-EV/Sales1.91EPS Y/Y TTM-Oper. Margin13.57%ATR (14)0.71Perf 10Y-
Dividend Ex-Date-Quick Ratio3.31Sales Y/Y TTM-Profit Margin-6.99%RSI (14)50.53Recom2.00
Dividend Gr. 3/5Y-Current Ratio5.26EPS Q/Q-2914.29%SMA20-4.24%Beta1.79Target Price15.00
Payout0.00%Debt/Eq0.54Sales Q/Q-10.26%SMA5010.94%Rel Volume8.73Prev Close11.65
Employees5,000LT Debt/Eq0.47EarningsNov 06SMA20032.24%Avg Volume1.45MPrice11.07
IPO DateSep 25, 2018Option/ShortYes / YesEPS/Sales Surpr.-2544.02% 0.91%Net Debt/EBITDA0.85Volume12,701,936Change-4.98%
Analyst Ratings
DateActionAnalystRatingTarget
Jul-20-26InitiatedCantor FitzgeraldOverweight$15
Latest News· Times ET
Sep-14-26
Sep-14-2604:14AM
Green Thumb Industries Positioned For Growth In Virginia Rec MarketsSeekingAlpha
Sep-11-26
Sep-11-2609:04AM
Trulieve: As Regulatory Headwinds Wane, Value Creation Is On The Cardsseekingalpha.com
Sep-08-26
Sep-08-2601:16PM
'Let's Go All In On Cannabis' Grown Rogue's Obie Strickler & Josh RosenSeekingAlpha
Sep-04-26
Sep-04-2604:00AM
Trulieve to Open Medical Cannabis Dispensary in Dunwoody, Georgiaprnewswire.com
Sep-02-26
Sep-02-2604:00AM
Trulieve Announces September 2026 Event Participationprnewswire.com
Aug-31-26
Aug-31-2610:41AM
3 Marijuana Stocks To Focus On For Future Growth And Profitsmarijuanastocks.com
Aug-18-26
Aug-18-2604:00AM
Trulieve to Ring The Closing Bell at the New York Stock Exchange as First U.S. Cannabis Company Listed on the NYSEprnewswire.com
Aug-12-26
Aug-12-2607:02AM
3 Marijuana Stocks For Investors To Considermarijuanastocks.com
Aug-11-26
Aug-11-2612:10PM
Trulieve Completes Redomicile from British Columbia to Delawareprnewswire.com
Aug-09-26
Aug-09-2604:08PM
Trulieve Cannabis: First NYSE-Listed Cannabis Stock Is A Buyseekingalpha.com
03:04AM
Trulieve Cannabis Q2 Earnings Call Highlightsmarketbeat.com
Aug-07-26
Aug-07-2612:44PM
Trulieve Cannabis Corp. (TRLV) Q2 2026 Earnings Call TranscriptSeekingAlpha
02:15AM
Trulieve Reports Second Quarter 2026 Resultsprnewswire.com
Aug-06-26
Aug-06-2605:30PM
Virginia and Texas Are About to Become Cannabis Battlegrounds. Here's Which Stocks Are Positioned to Win.fool.com
Aug-05-26
Aug-05-2604:00AM
Trulieve Announces August 2026 Event Participationprnewswire.com
Company

Trulieve Cannabis Corp. engages in the cultivation, processing, manufacturing, and retail distribution of medical and adult-use cannabis products. It cultivates and produces its products in-house and distributes to its branded stores, as well as directly to patients via home delivery. The company was founded by Kim Rivers & Jason Pernell on September 17, 1940 and is headquartered in Tallahassee, FL.

Ownership

Per-holder 13F data hasn't been ingested for this ticker yet.

Financial Statements
DataTimeframe
Line Item (USD, M)
TTM
—
FY 2025
12/31/2025
Total Revenue1,1391,181
Cost of Goods Sold Incl. D&A462470
Gross Profit677711
Selling, General and Administrative Excl. Other432445
Research and Development
00
Other Operating Expense520118
Operating Income-276148
Interest Expense5763
Unusual Expense
——
Non-Operating Income (Expense)57
Net Income Before Taxes-32691
Income Taxes145208
Consolidated Net Income-474-116
Net Income From Continuing Operations-471-117
Net Income-474-116
EPS (Recurring)-2.45-0.61
EPS (Basic, Before Extraordinaries)-2.45-0.61
EPS (Diluted)-2.45-0.61
EBITDA-139328
Other After Tax Adjustments
——
Stock Option Compensation Expense
——
Price To Earnings Ratio
——
Price To Sales Ratio1.881.41
Gross Margin59.4460.20
Operating Margin-24.2312.53
Net Margin-41.62-9.82
Shares Outstanding193191
Market Capitalization2,1371,660
Operating Lease Expense
——
Insider Trading Volume
$14.34$11.44$8.53$5.62$2.72● Close Price0.00M3.67M7.33M11.00M14.66MUSD Trades VolumeSepOctNovDec2026FebMarAprMayJunJulAugSep
Insider Trading
InsiderRelationshipDateTransactionCost#SharesValue ($)#Shares TotalSEC Form 4
Rivers Kim A.Chairman and CEOJun 26 '26Sale8.76136,8111,197,9171,476,913Jun 26
Rivers Kim A.Chairman and CEOJun 25 '26Sale8.17300,0002,450,7001,613,724Jun 25
Rivers Kim A.Chairman and CEOJun 24 '26Sale8.17400,0003,267,6001,913,724Jun 25
Rivers Kim A.Chairman and CEOJun 23 '26Sale8.47380,0003,218,2202,313,724Jun 25
Rivers Kim A.Chairman and CEOJun 22 '26Sale9.35204,8151,915,8402,693,724Jun 22
Rivers Kim A.Chairman and CEOJun 18 '26Sale9.46139,8461,322,9432,898,539Jun 22
Rivers Kim A.Chairman and CEOJun 17 '26Sale9.36137,5351,287,1903,038,385Jun 22
open in yahoo·open in reuters·open in marketwatch·open in google·open in EDGAR
QuoTrend signals describe historical patterns and statistics — educational information, not investment advice or a recommendation to buy or sell. Past performance doesn’t guarantee future results. Every figure traces to QuoTrend data. Historical patterns — not a prediction or advice.